RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:FDA's Head of CBER wants faster approvals with SE/biomarkers
Hey fox...the only thing is that no one knows if an offer has even been put forward and what the company would deem acceptable may be quite different from what the shareholders would accept so as a shareholder we are at the mercy of the company. Also in an earlier podcast this year matt was quoted as saying that he would like to see the panc and mbc through before handing it over so he may be the sticking point in all of this.
I do not necessarily think that an offer has been made as when they did the placement with the warrants it kinda said we can try this alone IMO only of course.
I kinda think this is a race to get this trial started asap before someone else steps in and beats us to the punch so they need to get this trial started before q1 2024 ends at the minimum.
Why it is taking so long for precision definitive agreements is beyond the scope of any of us as there has to be more going on than they are telling us or hope it to be so and that they are not being too needy.
Come on ESMO, please don't let us down